サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1436221

創薬の世界市場レポート 2024年

Drug Discovery Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
創薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

創薬の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には14.6%の年間複合成長率（CAGR）で1,922億米ドルに成長すると予想されます。予測期間中に予想される成長は、精密医療の導入、希少疾患への重点の集中、個別化治療の拡大によるものと考えられます。この期間に予想される主要動向としては、共同創薬モデル、希少疾患や希少疾病用医薬品への注目の高まり、マルチオミクスデータの統合、オルガノイドや3D細胞培養モデルの急速な採用、仮想スクリーニング技術の進歩などが挙げられます。

創薬市場は、世界の医療費の増加により成長が見込まれています。世界中の国々が国内総生産（GDP）のかなりの部分を医療費に割り当てており、病院ケア、医師と臨床サービス、専門サービス、歯科サービス、住宅とパーソナルケア、在宅医療、介護などのさまざまな要素が含まれます。施設、継続介護型退職者コミュニティ、処方薬など。 創薬は、病気の治療法の開発において重要な役割を果たし、健康状態の改善と寿命の延長に貢献するため、医療支出のかなりの部分を占めています。たとえば、2023年 12月、米国連邦機関であるCenters for Medicare & Medicaid Servicesは、2022年の米国の医療支出が4.1%増加し、1人当たり13,493ドルに相当する4兆5,000億米ドルに達したと報告しました。医療支出は国のGDPの17.3%を占めました。この多額の医療費は、新興疾患に対処するための新薬に対する継続的な需要を裏付けており、最終的に創薬市場の成長を促進します。

創薬市場は、ファーマバイオテクノロジー分野における研究開発（R&D）支出の増加により、成長の準備が整っています。ファーマバイオテクノロジー分野の研究開発支出には、新しい医薬品と技術の発見と研究開発活動に資金を割り当てることが含まれます。研究開発活動へのこの財政的取り組みは、病気のメカニズムの理解を進め、前臨床試験を実施し、臨床試験を進め、最終的には新しい薬や治療法の開発に貢献するために不可欠です。その一例として、英国政府は2022年に研究開発支出の大幅な増加を発表し、2024/25年までに年間200億（254億3,300万）ポンドに達するためにさらに5億ポンドを割り当てました。この資金注入は、全セクターを含む研究開発支出総額を2027年までにGDPの2.4%に達するという目標を達成するという政府の戦略の一環です。ファーマバイオテクノロジーセクターにおける研究開発支出の大幅な増加は、創薬を推進するという業界の取り組みを強調しています。これにより、創薬市場全体の成長が促進されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の創薬市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の創薬市場規模実績と成長、2018～2023年
  • 世界の創薬市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の創薬市場、医薬品のタイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 低分子
  • 高分子
  • 世界の創薬市場、プロセス別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 対象の選択
  • 対象の検証
  • ヒット・トゥ・リードの識別
  • リードの最適化
  • 候補者の検証
  • 世界の創薬市場、技術別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • ハイスループットスクリーニング
  • 分光法
  • コンビナトリアルケミストリー
  • バイオチップ
  • 薬理ゲノミクスと薬理遺伝学
  • バイオインフォマティクス
  • メタボロミクス
  • ナノ技術
  • その他
  • 世界の創薬市場、治療領域別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 腫瘍学
  • 神経内科
  • 感染症と免疫系疾患
  • 消化器系の病気
  • 心血管疾患
  • 糖尿病
  • 呼吸器疾患
  • その他
  • 世界の創薬市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 製薬会社
  • CRO
  • その他

第7章 地域と国の分析

  • 世界の創薬市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の創薬市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 創薬市場の競合情勢
  • 創薬市場の企業プロファイル
    • Pfizer Inc.
    • Merck &Co. Inc.
    • Novartis International AG
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec Group

第31章 その他の大手と革新的な企業

  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Laboratory Corporation of America Holdings
  • Evotec SE
  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Sanofi SA
  • Charles River Laboratories International Inc.
  • Pharmaron Ltd.
  • Viva Biotech Ltd.
  • Albany Molecular Research Inc.
  • Schrodinger Inc.
  • BioDuro Ltd.
  • Aptuit LLC
  • Selvita SA

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r15547

Drug discovery is the systematic process of identifying biologically active compounds with therapeutic potential. The journey from ideation to development and approval aims to discover new clinical drugs for treating various diseases, whether they are new, existing, or previously incurable.

The drug discovery market involves two main types of drugs include small molecule and large molecule. Small molecules are utilized to identify compounds with suitable properties for development, referring to low molecular weight drugs that can efficiently penetrate cells. The drug discovery process includes target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. Various technologies contribute to drug discovery, such as high throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics, pharmacogenetics, bioinformatics, metabolomics, nanotechnology, and others. Drug discovery finds applications in therapeutic areas such as oncology, neurology, infectious and immune system diseases, digestive system diseases, cardiovascular diseases, diabetes, respiratory diseases, and more. Pharmaceutical companies, Contract Research Organizations (CROs), and other end-users engage in drug discovery.

The drug discovery market research report is one of a series of new reports from The Business Research Company that provides drug discovery market statistics, including drug discovery industry global market size, regional shares, competitors with a drug discovery market share, detailed drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery industry. This drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug discovery market size has grown rapidly in recent years. It will grow from $98.01 billion in 2023 to $111.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth observed in the historic period can be attributed to advancements in genomics and proteomics, the increasing prevalence of chronic diseases, and the emergence of biopharmaceuticals.

The drug discovery market size is expected to see rapid growth in the next few years. It will grow to $192.2 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The anticipated growth in the forecast period can be attributed to the adoption of precision medicine, a heightened focus on rare diseases, and the expansion of personalized therapies. Major trends expected in this period include collaborative drug discovery models, an increased focus on rare diseases and orphan drugs, the integration of multi-omics data, rapid adoption of organoids and 3D cell culture models, and advancements in virtual screening techniques.

The drug discovery market is anticipated to experience growth, propelled by the rising healthcare expenditure worldwide. Countries across the globe allocate a significant portion of their Gross Domestic Product (GDP) to healthcare expenses, encompassing various components such as hospital care, physician and clinical services, professional services, dental services, residential and personal care, home health care, nursing care facilities, continuing care retirement communities, prescription drugs, and others. Drug discovery constitutes a substantial share of healthcare expenditure, as it plays a crucial role in the development of treatments for diseases, contributing to improved health outcomes and extended lifespans. For example, in December 2023, the Centers for Medicare & Medicaid Services, a US federal agency, reported that US healthcare spending in 2022 witnessed a 4.1% increase, reaching $4.5 trillion, equivalent to $13,493 per person. Health spending accounted for 17.3% of the country's GDP. This substantial healthcare expenditure underscores the ongoing demand for new drugs to address emerging diseases, ultimately driving the growth of the drug discovery market.

The drug discovery market is poised for growth, driven by the increasing research and development (R&D) expenditure in the pharma-biotech sector. R&D expenditure in the pharma-biotech sector involves allocating funds for research and development activities, focusing on the discovery and development of new pharmaceutical products and technologies. This financial commitment to R&D activities is essential for advancing the understanding of disease mechanisms, conducting pre-clinical testing, and progressing through clinical trials, ultimately contributing to the development of new medicines and treatments. As an illustration, in 2022, the UK government announced a significant increase in spending on R&D, allocating an additional £5 (6.36) billion to reach £20 (25.43) billion per year by 2024/25. This funding injection is part of the government's strategy to achieve a target of total R&D spending, encompassing all sectors, reaching 2.4% of GDP by 2027. The substantial growth in R&D expenditure in the pharma-biotech sector underscores the industry's commitment to advancing drug discovery, thus propelling the overall growth of the drug discovery market.

Technological advancements play a crucial role in shaping the landscape of the drug discovery market. Companies within this domain are actively incorporating various cutting-edge technologies, including Artificial Intelligence (AI), imaging technology, and others, to streamline and expedite the drug discovery process. This proactive integration of technology aims to reduce the time required for drug discovery, fostering innovation and efficiency in the industry. Imaging technology is a notable aspect of these advancements, enabling the visualization, characterization, and quantification of non-invasive biological activities occurring within organisms in response to medications. These methods, utilizing either probes or the tissue itself, are instrumental in comprehending diseases and identifying novel treatments. As an illustrative example, in May 2023, Google Cloud introduced two AI-powered tools in the drug discovery realm: the Target and Lead Identification Suite and the Multiomics Suite. These tools are designed to empower biotech and pharmaceutical companies by expediting drug discovery and precision medicine efforts. The Target and Lead Identification Suite aids in deciphering the function of amino acids and proteins, while the Multiomics Suite accelerates the discovery and interpretation of genomic data, facilitating the design of precision treatments. This commitment to leveraging advanced technologies exemplifies the industry's dedication to enhancing the drug discovery process through innovative tools and approaches.

Major players in the drug discovery market are actively engaged in creating innovative solutions, such as drug discovery accelerators, to advance the development of sophisticated drug models. Drug discovery accelerators represent various entities, initiatives, or programs meticulously crafted to expedite the intricate process of discovering and developing novel pharmaceutical compounds. An exemplary instance of this commitment to innovation is evident in the collaboration between Novo Nordisk and Evotec. In September 2023, they jointly introduced LAB eN2, a translational drug discovery accelerator. LAB eN2 is specifically crafted to support preclinical research originating from academic institutions, with the ultimate goal of propelling the development of groundbreaking therapeutics. The collaboration's primary focus is to hasten the translation of academic concepts into tangible therapeutic product candidates, particularly within the realms of cardiometabolic disorders, rare blood disorders, and endocrine disorders.

In October 2021, Inotiv, a US-based contract research organization specializing in nonclinical and analytical drug discovery and development services, completed the acquisition of Plato BioPharma for $15 million. This strategic move by Inotiv aligns with its overarching strategy to expand its portfolio of contract research services, covering the entire spectrum of drug discovery and preclinical development processes. Plato BioPharma, a US-based company with expertise in in vivo pharmacology research, focuses on drug discovery within therapeutic areas such as cardiovascular, renal, pulmonary, and hepatic domains.

Major companies operating in the drug discovery market report are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrodinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

North America was the largest region in the drug discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug discovery market includes revenues earned by entities by high throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics and pharmacogenetics, bioinformatics, metabolomics, and nanotechnology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Discovery Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Type: Small Molecule; Large Molecule
  • 2) By Process: Target Selection; Target Validation; Hit-To-Lead Identification; Lead Optimization; Candidate Validation
  • 3) By Technology: High Throughput Screening; Spectroscopy; Combinatorial Chemistry; Biochips; Pharmacogenomics and Pharmacogenetics; Bioinformatics; Metabolomics; Nanotechnology; Other Technologies
  • 4) By Therapeutic Area: Oncology; Neurology; Infectious and Immune System Diseases; Digestive System Diseases; Cardiovascular Diseases; Diabetes; Respiratory Disease; Other Therapeutic Areas
  • 5) By End User: Pharmaceutical Companies; CROs; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Novartis International AG; Thermo Fisher Scientific Inc.; WuXi AppTec Group
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Discovery Market Characteristics

3. Drug Discovery Market Trends And Strategies

4. Drug Discovery Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Discovery Market Size and Growth

  • 5.1. Global Drug Discovery Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Discovery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Discovery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Discovery Market Segmentation

  • 6.1. Global Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Molecule
  • Large Molecule
  • 6.2. Global Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Target Selection
  • Target Validation
  • Hit-To-Lead Identification
  • Lead Optimization
  • Candidate Validation
  • 6.3. Global Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • High Throughput Screening
  • Spectroscopy
  • Combinatorial Chemistry
  • Biochips
  • Pharmacogenomics and Pharmacogenetics
  • Bioinformatics
  • Metabolomics
  • Nanotechnology
  • Other Technologies
  • 6.4. Global Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Neurology
  • Infectious and Immune System Diseases
  • Digestive System Diseases
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Disease
  • Other Therapeutic Areas
  • 6.5. Global Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • CROs
  • Other End-Users

7. Drug Discovery Market Regional And Country Analysis

  • 7.1. Global Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Discovery Market

  • 8.1. Asia-Pacific Drug Discovery Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Discovery Market

  • 9.1. China Drug Discovery Market Overview
  • 9.2. China Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Discovery Market

  • 10.1. India Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Discovery Market

  • 11.1. Japan Drug Discovery Market Overview
  • 11.2. Japan Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Discovery Market

  • 12.1. Australia Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Discovery Market

  • 13.1. Indonesia Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Discovery Market

  • 14.1. South Korea Drug Discovery Market Overview
  • 14.2. South Korea Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Discovery Market

  • 15.1. Western Europe Drug Discovery Market Overview
  • 15.2. Western Europe Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Discovery Market

  • 16.1. UK Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Discovery Market

  • 17.1. Germany Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Discovery Market

  • 18.1. France Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Discovery Market

  • 19.1. Italy Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Discovery Market

  • 20.1. Spain Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Discovery Market

  • 21.1. Eastern Europe Drug Discovery Market Overview
  • 21.2. Eastern Europe Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Discovery Market

  • 22.1. Russia Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Discovery Market

  • 23.1. North America Drug Discovery Market Overview
  • 23.2. North America Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Discovery Market

  • 24.1. USA Drug Discovery Market Overview
  • 24.2. USA Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Discovery Market

  • 25.1. Canada Drug Discovery Market Overview
  • 25.2. Canada Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Discovery Market

  • 26.1. South America Drug Discovery Market Overview
  • 26.2. South America Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Discovery Market

  • 27.1. Brazil Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Discovery Market

  • 28.1. Middle East Drug Discovery Market Overview
  • 28.2. Middle East Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Discovery Market

  • 29.1. Africa Drug Discovery Market Overview
  • 29.2. Africa Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Discovery Market Competitive Landscape And Company Profiles

  • 30.1. Drug Discovery Market Competitive Landscape
  • 30.2. Drug Discovery Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novartis International AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. WuXi AppTec Group
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drug Discovery Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline plc
  • 31.2. Eli Lilly and Company
  • 31.3. Laboratory Corporation of America Holdings
  • 31.4. Evotec SE
  • 31.5. Eurofins Scientific SE
  • 31.6. Agilent Technologies Inc.
  • 31.7. Sanofi S.A.
  • 31.8. Charles River Laboratories International Inc.
  • 31.9. Pharmaron Ltd.
  • 31.10. Viva Biotech Ltd.
  • 31.11. Albany Molecular Research Inc.
  • 31.12. Schrodinger Inc.
  • 31.13. BioDuro Ltd.
  • 31.14. Aptuit LLC
  • 31.15. Selvita S.A.

32. Global Drug Discovery Market Competitive Benchmarking

33. Global Drug Discovery Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Discovery Market

35. Drug Discovery Market Future Outlook and Potential Analysis

  • 35.1 Drug Discovery Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drug Discovery Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drug Discovery Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer